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Background
Metformin improves cardiovascular outcomes in dia-
betes, but its mechanism of action is controversial.
Recent evidence suggests that Metformin reduces gluco-
neogenesis by altering hepatic redox state. Whether
Metformin also alters cardiac redox state and metabo-
lism is unknown, in part because of the difficulty in
measuring cardiac metabolism in vivo. Hyperpolarized
[1-13C]pyruvate magnetic resonance spectroscopy can
assess the redox coupled interconversion of pyruvate
and lactate with spatial localization to the heart. We
therefore used hyperpolarized [1-13C]pyruvate magnetic
resonance spectroscopy to investigate the effects of
acute and chronic metformin treatment upon cardiac
and hepatic metabolism.
Methods
In the first study, male Wistar rats (n = 10 per group)
were given an intravenous infusion of either 50 mg
Metformin or saline. Hyperpolarized [1-13C]pyruvate
spectroscopy was performed 45 minutes later, with slice
selective spectra acquired from two axial slabs covering
the heart and liver using a 7T preclinical MR system
and a volume 13C transmit / two-channel surface receive
RF coil. We next tested the effects of longer term Met-
formin treatment (4 weeks) in both control rats and rats
with a high-fat feeding and streptozotocin induced
model of type II diabetes (n = 6-8 per group). We again
used hyperpolarized [1-13C]pyruvate spectroscopy to
assess cardiac and hepatic metabolism, and also per-
formed echocardiography to assess cardiac diastolic
function.
Results
A single Metformin infusion significantly increased the
cardiac [1-13C]lactate:[1-13C]pyruvate ratio (0.22 ± 0.04
versus 0.11 ± 0.01, P < 0.05, Figure 1) without changing
pyruvate dehydrogenase flux ([1-13C]bicarbonate:[1-13C]
pyruvate ratio 0.07 ± 0.009 versus 0.08 ± 0.006, P = ns).
Longer term Metformin treatment for 4 weeks also
increased the cardiac [1-13C]lactate:[1-13C]pyruvate ratio
in both control rats (0.26 ± 0.01 versus 0.10 ± 0.01, P <
0.05) and in diabetic rats (0.21 ± 0.03 versus 0.14 ±
0.02, P < 0.05). Surprisingly, Metformin also reduced
cardiac pyruvate dehydrogenase flux in both control
(0.04 ± 0.08 versus 0.05 ± 0.004, P < 0.05) and diabetic
rats (0.007 ± 0.001 versus 0.02 ± 0.003, P < 0.05). Simi-
lar changes in both [1-13C]lactate and [1-13C]bicarbo-
nate production were present in the liver. Diabetes
was associated with diastolic but not systolic dysfunction
(E/E’ ratio 18 ± 1.4 versus 15 ± 0.8, P < 0.05), which was
not changed by Metformin treatment (E/E’ ratio 17 ±
1.2, versus 18 ± 1.4, P = ns).
Conclusions
Both acute and chronic metformin treatment signifi-
cantly increased the cardiac [1-13C]lactate:[1-13C]pyru-
vate ratio, likely reflecting a shift in cardiac redox state.
These findings suggest that hyperpolarized 1-13C]pyru-
vate magnetic resonance spectroscopy is sensitive to
Metformin induced changes in redox biology and can
identify novel cardiac metabolic effects of this com-
monly prescribed drug.
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